Pinnacle Digest

Technology

From bleeding-edge AI to transformative hardware, we track the innovators and breakthroughs redefining how the world works, communicates, and invests.

January 5, 2024

AI Uncovered: How Machine Minds are Transforming Our World

AI integration is set to change all of our lives in the coming few years. Understanding where that change happens will make the difference.

June 1, 2023

AI Stocks Rally as Base Metals and Energy Fade in

C3.Ai added more than $2 billion to its market cap in the month of May. Tech stocks outperformed in May as base metals weakened.

August 25, 2021

Clinical Director of Imperial College’s Center for Psychedelic Research Joins

Dr. David Erritzoe to provide guidance on psychopharmacological research

August 24, 2021

Entheon Biomedical Corp. Announces DTC Eligibility

Entheon Biomedical Corp. is pleased to announce that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company

August 12, 2021

Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess

a biotechnology company focused on developing psychedelic medicines to treat addiction, today announced the sponsorship of a clinical research study with Heading Health LLC

November 30, 2017

LexaGene Completes Prototype Assembly for Soon-To-Be First Fully Automated, Open-Access

LexaGene Holdings completes prototype assembly for its soon-to-be first fully automated, open-access Pathogen Detection System.

November 28, 2017

LexaGene Holdings Inc. Announces C$5.0 Million Bought Deal

LexaGene Holdings announces bought deal for potential gross proceeds of C$5 million.

November 22, 2017

BeWhere Reports 3rd Quarter Financial Results Hit Record Revenue Level

BeWhere Holdings reported this morning that revenues increased 804% year-over-year for the nine-month period. Gross profits also surged.

November 9, 2017

Bell, Huawei and BeWhere bring new Internet of Things solution

BeWhere and Bell implement IoT smart technology solutions for Ontario vineyard Henry of Pelham in smart agriculture vineyard.

November 5, 2017

Our New Favourite Industry to Invest In…

BeWhere is targeting the Low-power WAN (LPWAN) expansion which is designed to function within machine-to-machine and IoT networks.

October 22, 2017

Rise of the Machines

Machine learning enabled through A.I. and the Internet of Things will make millions of jobs disappear and usher in the fourth industrial revolution.

October 12, 2017

‘Rainendown’ and ‘mjca’ lead October Stock Challenge with Global Blockchain

Global Blockchain Technologies is up massively in recent months as retail investors rush into the blockchain sector with reckless abandon.

September 22, 2017

Another CSE Tech Deal Takes Off

Glance Technologies is the latest CSE tech deal to break out. Investors are speculating the micro-cap can capitalize on the growing online security sector.

August 15, 2017

LexaGene Names Life Sciences Veteran Manohar Furtado to Board of

LexaGene appoints Manohar Furtado, Ph.D., to its Board of Directors. LexaGene’s pre-alpha prototype is scheduled to be complete by the end of November.

August 12, 2017

iLOOKABOUT Rebounds from 52-Week Low

iLOOKABOUT rips 16% nearly one month after announcing a multi-year contract renewal with the Municipal Property Assessment Corporation.

July 21, 2017

POET Technologies Continues Rebound from 52-Week Low

POET stock has been gobbled up by investors in recent trading days. After bottoming at $0.175 per share, POET has gained 10 cents in value.

July 20, 2017

Edgewater Wireless | Still Closing Deals Amidst Dilution

Edgewater Wireless WiFi3(TM) technology is patented and designed to solve slow connections in high-density locations. Mediacom struck a deal with Edgewater.

Join The Community

Join 75,000+ Independent Investors

Get sharp, weekly insight on capital flows, commodity cycles, and macro trends shaping tomorrow’s markets.

* By submitting your email you will receive our best content in your inbox weekly, which sometimes includes information about our sponsors. And you also agree to our Terms of Use  and Privacy Policy.
Thank you! You are now subscribed.
We're sorry, but there was an error processing your submission.